Kyndryl Holdings Inc vs Medpace Holdings Inc — how do they compare? Kyndryl Holdings Inc trades at $12.19 (market cap $2.69B), while Medpace Holdings Inc trades at $530.22 (market cap $15.08B). The key difference: Medpace Holdings Inc is far larger — about 5.6× Kyndryl Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals.
| KD | MEDP | |
|---|---|---|
Market Cap | $2.69B | $15.08B |
Sector | Technology | Technology |
52-Week High | $39.47 | $620.59 |
52-Week Low | $10.59 | $308.88 |
Enterprise Value | $5.03B | $14.55B |
Trailing returns across standard periods
Latest headlines on both assets
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →